Septic arthritis due to Salmonella enteritidis associated with infliximab use

Ioannis Katsarolis; Sotirios Tsiodras; Periklis Panagopoulos; Efthymia Giannitsioti; Grigorios Skarantavos; Theologos Ioannidis; Helen Giamarellou

doi:10.1080/00365540410021171

Septic arthritis due to Salmonella enteritidis associated with infliximab use

Scand J Infect Dis. 2005;37(4):304-5. doi: 10.1080/00365540410021171.

Authors

Ioannis Katsarolis¹, Sotirios Tsiodras, Periklis Panagopoulos, Efthymia Giannitsioti, Grigorios Skarantavos, Theologos Ioannidis, Helen Giamarellou

Affiliation

¹ Fourth Department of Internal Medicine, Attikon University General Hospital, Athens University Medical School, Athens, Greece. [email protected]

PMID: 15804667
DOI: 10.1080/00365540410021171

Abstract

A unique case of septic arthritis caused by Salmonella enteritidis in a patient receiving infliximab for rheumatoid arthritis is presented. Antimicrobial chemotherapy with surgical intervention was necessary for eradication of the infection. Physicians should be aware of rare manifestations of Salmonella infections associated with infliximab use, especially in endemic areas.

Publication types

Case Reports

MeSH terms

Antibodies, Monoclonal / adverse effects*
Antirheumatic Agents / adverse effects*
Arthritis, Infectious / chemically induced*
Arthritis, Infectious / microbiology
Female
Humans
Infliximab
Middle Aged
Salmonella Infections / chemically induced*
Salmonella Infections / microbiology
Salmonella enteritidis / isolation & purification*
Tumor Necrosis Factor-alpha / antagonists & inhibitors

Substances

Antibodies, Monoclonal
Antirheumatic Agents
Tumor Necrosis Factor-alpha
Infliximab